Table 5.
Characteristic | DFS 3 years | DFS 5 years | Death 3 years | Death 5 years | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
RR | 95% CI | P | RR | 95% CI | P | RR | 95% CI | P | RR | 95% CI | P | |
Sex | ||||||||||||
Male | ||||||||||||
Female | 1.202 | 0.839–1.721 | 0.316 | 1.137 | 0.811–1.595 | 0.457 | 1.307 | 0.861–1.984 | 0.208 | 1.413 | 0.956–2.088 | 0.082 |
Age (years) | ||||||||||||
<1 | 4.288 | 0.531–34.611 | 0.172 | 3.947 | 0.495–31.454 | 0.195 | 0.000 | 0.000 | 0.000 | 3.616 | 0.446–29.352 | 0.229 |
1–5 | 1 | 1 | 1 | 1 | ||||||||
5.1–9.99 | 1.504 | 0.942–2.403 | 0.087 | 1.384 | 0.891–2.148 | 0.148 | 1.556 | 0.887–2.728 | 0.123 | 4.573 | 0.940–2.633 | 0.085 |
>10 | 1.464 | 0.958–2.239 | 0.078 | 1.358 | 0.912–2.021 | 0.132 | 1.699 | 1.036–2.787 | 0.036 | 1.561 | 0.982–2.479 | 0.060 |
Leucocytes (1 × 109/L) | ||||||||||||
<10 | ||||||||||||
10–20 | 1.302 | 0.792–2.140 | 0.297 | 1.489 | 0.942–2.354 | 0.089 | 1.437 | 0.821–2.516 | 0.205 | 1.495 | 0.876–2.550 | 0.140 |
20–50 | 1.193 | 0.655–2.175 | 0.564 | 1.253 | 0.712–2.205 | 0.435 | 1.286 | 0.650–2.545 | 0.470 | 1.322 | 0.688–2.541 | 0.402 |
50–100 | 1.133 | 0.520–2.470 | 0.753 | 1.167 | 0.556–2.449 | 0.683 | 0.990 | 0.390–2.510 | 0.982 | 1.374 | 0.620–3.044 | 0.434 |
>100 | 1.842 | 1.033–3.285 | 0.038 | 2.025 | 1.172–3.496 | 0.011 | 1.604 | 0.833–3.088 | 0.158 | 1.860 | 1.011–3.422 | 0.046 |
Phenotype | ||||||||||||
B | ||||||||||||
T | 1.676 | 0.893–3.145 | 0.108 | 1.479 | 0.794–2.754 | 0.218 | 2.071 | 1.054–4.070 | 0.035 | 1.930 | 1.017–3.664 | 0.044 |
Risk | ||||||||||||
Standard | ||||||||||||
High | 0.765 | 0.481–1.216 | 0.258 | 0.753 | 0.485–1.169 | 0.206 | 0.823 | 0.487–1.388 | 0.464 | 0.830 | 0.503–1.371 | 0.467 |
DFS: disease-free survival; RR: relative risk; CI: confidence interval.